Use the strongest question, not the broadest promise
The supplied assessment recommends CRISPR as a research capability for testing causes of cellular dysfunction and possible restoration of useful function. Its reviewed studies do not establish safe reversal of normal aging throughout a human body.
A successful perturbation in a cell model is valuable because it can clarify mechanism. It remains a different kind of evidence from a patient outcome or a durable clinical benefit.
[C01] [C02] [C03] [C11] [C12] [C15] [C16] [C20]
Keep four outcomes separate
Senolysis removes senescent cells. A senomorphic intervention reduces damaging senescence-associated behavior. Functional restoration seeks to improve surviving cells. Escape from growth arrest may simply permit damaged cells to divide.
Those outcomes require different measurements. A fall in the average marker level could result from selective death; a proliferation signal could reflect expansion of a subset rather than repair of the original population.
[C01] [C02] [C03] [C11] [C12] [C15] [C16] [C20]
Read the recent target findings in context
GNPTAB–STING provides a selective-signaling lead in human-cell models. Aging T-cell screens provide context-specific immune-function findings, including mouse tumor evidence. Neither establishes whole-body rejuvenation.
The SRSF1 result is relevant but was not discovered in a CRISPR screen. Karam treats potential CRISPRa follow-up as a hypothesis and retains the small animal-cohort limitation of the underlying study.
[C01] [C02] [C03] [C11] [C12] [C15] [C16] [C20]
Human evidence does not remove the distinction
The assessment includes CTX310 as early, disease-related in vivo editing evidence and ER-100 as an early sponsor-reported reprogramming example. ER-100 is not CRISPR-Cas9 editing.
Biomarker changes and a few early observations should not be converted into claims of extended human lifespan. For Karam, the immediate objective is a reproducible target dossier, meaningful endpoints and qualified follow-up—not a consumer age-reversal treatment.